![Diane J. Kalina](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Diane J. Kalina
President at BioCatalyst Yorkton, Inc.
Network origin in Diane J. Kalina first degree
Entity | Entity type | Industry | |
---|---|---|---|
Arius Research, Inc.
![]() Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada.
8
| Extinct | Biotechnology | 8 |
BioCatalyst Yorkton, Inc.
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Diane J. Kalina via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
American Society of Hematology
![]() American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
American Association for Cancer Research
![]() American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Resolution Pharmaceuticals, Inc. | Chief Executive Officer Director of Finance/CFO | ||
TELESTA THERAPEUTICS INC | Pharmaceuticals: Other | Chairman Director/Board Member | |
PlantForm Corp.
![]() PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director/Board Member Chairman | |
PROMIS NEUROSCIENCES, INC. | Biotechnology | Director of Finance/CFO Chief Executive Officer | |
Pharmx, Inc. | Director/Board Member | ||
Northwestern University School of Law | College/University | Graduate Degree | |
BVF Partners LP
![]() BVF Partners LP Investment ManagersFinance BVF Partners LP (BVF) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 1993 and is a subsidiary of BVF, Inc. BVF provides discretionary advisory services to private investment vehicles which includes commingled limited partnerships (the BVF Funds) and a limited liability entity organized for a single investor (Single Investor Fund) as well as to separately managed accounts. | Investment Managers | Chief Executive Officer | |
MedClaims Liaison LLC
![]() MedClaims Liaison LLC Insurance Brokers/ServicesFinance MedClaims Liaison LLC provides healthcare reimbursement services. The private company is based in Ridgefield, CT. The company was founded in 2009 by Mitchell D. Kaye, Nancy Kaye. | Insurance Brokers/Services | Chief Executive Officer | |
AEOLUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
NAVIGANT CONSULTING, INC. | Miscellaneous Commercial Services | Director/Board Member | |
Wesleyan University | College/University | Undergraduate Degree | |
Xmark Fund Ltd. | Chief Investment Officer | ||
Navigant Capital Advisors LLC
![]() Navigant Capital Advisors LLC Investment ManagersFinance Navigant Capital Advisors LLC provides investment banking services. It offers fairness opinion, mergers and acquisition, private placement, due diligence, divestiture, leveraged recapitalization and refinancing, debt and equity underwriting and business turnaround advisory services. The company is headquartered in Chicago, IL. | Investment Managers | Corporate Officer/Principal | |
Remedies Health Care Services, Inc. | Founder | ||
Vaxis Therapeutics Corp
![]() Vaxis Therapeutics Corp Pharmaceuticals: MajorHealth Technology Part of DMK Pharmaceuticals Corp., Vaxis Therapeutics Corp manufactures and researches pharmaceutical products. The company is based in Kingston, Canada. Vaxis Therapeutics was acquired by Cellegy Pharmaceuticals, Inc. on November 29, 2001 for $4 million. | Pharmaceuticals: Major | Chief Executive Officer | |
Viron Therapeutics, Inc.
![]() Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
Aegera Therapeutics, Inc.
![]() Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Biotechnology | Chairman | |
Cita NeuroPharmaceuticals, Inc.
![]() Cita NeuroPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Director/Board Member | |
ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
The New York City Investment Fund Manager, Inc.
![]() The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager Inc. (The New York City Investment Fund Manager) is a venture capital firm founded by Henry Kravis in 1996. The firm is headquartered in New York, United States. | Investment Managers | Consultant / Advisor | |
BIONOMICS LIMITED | Pharmaceuticals: Generic | Director/Board Member | |
Sabbatical Ventures LLC | Founder | ||
New York Alzheimers Association | Director/Board Member | ||
American Society of Clinical Oncology, Inc.
![]() American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
Toxin Alert, Inc.
![]() Toxin Alert, Inc. Medical SpecialtiesHealth Technology Toxin Alert, Inc. is a biotechnology company engaged in protecting consumers from unsafe food. It is currently focused on U.S. patented Toxin Guard for food freshness and safety test, which will have its first commercial application in food packaging materials. The company was founded on September 15, 1998 and is headquartered in Toronto, Canada. | Medical Specialties | Director/Board Member | |
New York Medical College | College/University | Doctorate Degree | |
St. Mary's College of California | College/University | Masters Business Admin | |
Bayer Corp.
![]() Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
XOMA (US) LLC
![]() XOMA (US) LLC Pharmaceuticals: MajorHealth Technology XOMA (US) LLC develops pharmaceutical preparations. It offers proprietary drugs and toiletries. The company is headquartered in Emeryville, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Elusys Therapeutics, Inc.
![]() Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
SCORPIUS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Chatham Consulting Group, Inc. | Founder | ||
University of Illinois | College/University | Doctorate Degree | |
The Massachusetts Medical Society
![]() The Massachusetts Medical Society Miscellaneous Commercial ServicesCommercial Services The Massachusetts Medical Society provides health care information solutions and services. The firm offers public health and medical education, legislative, regulatory advocacy, and health policy research for physicians and patients in the United States. The company was founded on November 1, 1781 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
SATELLOS BIOSCIENCE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Frontera Therapeutics (HK) Ltd.
![]() Frontera Therapeutics (HK) Ltd. Pharmaceuticals: MajorHealth Technology Part of Frontera Therapeutics, Inc., Frontera Therapeutics (HK) Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company was founded by Yong Dai and Yong Dai has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
STAGEZERO LIFE SCIENCES LTD. | Medical Specialties | Comptroller/Controller/Auditor | |
University of Western Ontario | College/University | Undergraduate Degree | |
APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
United States | 30 |
Canada | 19 |
Australia | 2 |
Hong Kong | 2 |
Sectoral
Health Technology | 26 |
Finance | 7 |
Consumer Services | 7 |
Commercial Services | 5 |
Health Services | 3 |
Operational
Director/Board Member | 77 |
Independent Dir/Board Member | 24 |
Corporate Officer/Principal | 20 |
Chairman | 10 |
Chief Executive Officer | 8 |
Most connected contacts
Insiders | |
---|---|
Carl Gordon | 59 |
Mitchell Kaye | 16 |
Warren Whitehead | 14 |
James Moodie Rae | 12 |
Robert Gundel | 10 |
George W. Masters | 6 |
Daniel S. Pereira | 6 |
Daniel B. Rubinstein | 6 |
Dan Andersen | 3 |
- Stock Market
- Insiders
- Diane J. Kalina
- Company connections